Reduction in C-reactive protein indicates successful targeting of the IL-1/IL-6 axis resulting in improved survival in early stage multiple myeloma

Myeloma today: Disease definitions and treatment advances

(2015) S. Vincent Rajkumar   AMERICAN JOURNAL OF HEMATOLOGY

Inflammation-Induced Cell Proliferation Potentiates DNA Damage-Induced Mutations In Vivo

(2015) Orsolya Kiraly et al.   PLoS Genetics

Smoldering multiple myeloma requiring treatment: time for a new definition?

(2013) A. Dispenzieri et al.   BLOOD

Association Between World Trade Center Exposure and Excess Cancer Risk

(2013) Jiehui Li et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma

(2013) María-Victoria Mateos et al.   NEW ENGLAND JOURNAL OF MEDICINE

Why not treat human cancer with interleukin-1 blockade?

(2010) Charles A. Dinarello   CANCER AND METASTASIS REVIEWS

Multiple Myeloma in World Trade Center Responders: A Case Series

(2009) Jacqueline M. Moline et al.   JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE

Targeting the Pathogenic Role of Interleukin 1β in the Progression of Smoldering/Indolent Myeloma to Active Disease

(2009) Charles A. Dinarello   MAYO CLINIC PROCEEDINGS

Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component

(2009) John A. Lust et al.   MAYO CLINIC PROCEEDINGS